Cargando…
Patient-reported symptoms and interest in symptom monitoring in HCC treated with locoregional therapies: A qualitative study
BACKGROUND: Patient-reported outcomes (PRO) measures relevant to domains most important to patients with HCC who received locoregional therapies are needed to advance patient-centered research. Furthermore, electronic PRO monitoring in clinical care has been shown to reduce hospitalizations and deat...
Autores principales: | Moon, Andrew M., Cook, Sarah, Swier, Rachel M., Sanoff, Hanna K., Kappelman, Michael D., Wagner, Lynne I., Barritt, A. Sidney, Singal, Amit G., Shah, Neil D., Mauro, David M., Yanagihara, Ted K., Gerber, David A., Fried, Michael W., Brown, Cristal, Waheed, Myra, Teal, Randall, Evon, Donna M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629737/ https://www.ncbi.nlm.nih.gov/pubmed/37930127 http://dx.doi.org/10.1097/HC9.0000000000000315 |
Ejemplares similares
-
Reply : Understanding survival comparisons in non-randomized treatment comparisons for patients with early-stage HCC
por: Moon, Andrew M., et al.
Publicado: (2023) -
Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation
por: Crocetti, Laura, et al.
Publicado: (2021) -
Multimodality locoregional treatment strategies for bridging HCC patients before liver transplantation
por: Györi, Georg P., et al.
Publicado: (2017) -
Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC
por: Biondetti, Pierpaolo, et al.
Publicado: (2021) -
Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives
por: Iezzi, Roberto, et al.
Publicado: (2023)